title: Pelvic adhesions contain sex steroid receptors and produce angiogenesis growth factors.
abstract: OBJECTIVE
  To evaluate female pelvic adhesion tissue for the presence of estrogen receptor (ER), progesterone receptor (PR), basic fibroblastic growth factor (basic-FGF), and vascular endothelial growth factor (VEGF).
  
  
  METHODS
  Descriptive study.
  
  
  METHODS
  Patients at a tertiary medical center.
  
  
  METHODS
  Female reproductive age patients undergoing gynecologic surgery who were not receiving hormonal therapy.
  
  
  METHODS
  Female reproductive tract peritoneal adhesion tissue was excised, frozen, and sent for immunohistologic evaluation.
  
  
  METHODS
  Presence of ER, PR, basic-FGF, and VEGF in adhesion tissue.
  
  
  RESULTS
  Nineteen of 19 specimens were positive for PR; 16 of 19 specimens were positive for ER, which was present in a variety of the different cell types constituting adhesion. Vascular endothelial growth factor and basic-FGF were detected in endothelial cells of blood vessels supplying this tissue as well as in mesothelial cells.
  
  
  CONCLUSIONS
  Adhesion tissue contains ER, PR, and growth factors that may be important in the genesis of the permanent fibrovascular bands between pelvic organs. This supports the theoretical possibility of hormonal manipulation of these tissues to negatively influence postoperative pelvic adhesion formation.
authors.affiliation: Department of Obstetrics and Gynecology, Tufts University School of Medicine, Springfield, Massachusetts, USA.
authors.forename: H P
authors.initials: HP
authors.lastname: Wiczyk
authors.forename: D R
authors.initials: DR
authors.lastname: Grow
authors.forename: L A
authors.initials: LA
authors.lastname: Adams
authors.forename: D L
authors.initials: DL
authors.lastname: O'Shea
authors.forename: M T
authors.initials: MT
authors.lastname: Reece
mesh_terms: D000328:Adult; D004715:Endometriosis / Q000378:metabolism / Q000473:pathology; D016228:Endothelial Growth Factors / Q000032:analysis*; D004730:Endothelium, Vascular / Q000737:chemistry; D005260:Female; D016222:Fibroblast Growth Factor 2 / Q000032:analysis*; D005347:Fibroblasts / Q000737:chemistry; D006801:Humans; D007150:Immunohistochemistry; D008222:Lymphokines / Q000032:analysis*; D009131:Muscle, Smooth, Vascular / Q000737:chemistry; D010532:Peritoneal Diseases / Q000378:metabolism*; D011960:Receptors, Estrogen / Q000032:analysis*; D011980:Receptors, Progesterone / Q000032:analysis*; D000267:Tissue Adhesions / Q000378:metabolism*; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
chemical_list: D016228:Endothelial Growth Factors; D008222:Lymphokines; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D016222:Fibroblast Growth Factor 2